AbCellera to Present at Upcoming Investor Conferences in November 2024

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) has announced its participation in two upcoming investor conferences in November 2024. The company's executives will be presenting at:

• The Stifel Healthcare Conference on Monday, November 18, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)
• The Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 10:00 a.m. Pacific Time (5:00 p.m. Greenwich Mean Time)

Live audio webcasts of both presentations will be accessible through links posted on AbCellera's Investor Relations website. Replays of the webcasts will also be available through the same links after the presentations conclude.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will be presenting at the following investor conferences:

• Stifel Healthcare Conference on Monday, November 18, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time)
• Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 10:00 a.m. Pacific Time (5:00 p.m. Greenwich Mean Time)

Live audio webcasts of each presentation may be accessed through links that will be posted on AbCellera's Investor Relations website. Replays of each webcast will be available through the same links following the presentations.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. AbCellera’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the most challenging antibody discovery problems. AbCellera is focused on advancing an internal pipeline of first-in-class and best-in-class programs and collaborating on innovative drug development programs with partners. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241022678878/en/

Inquiries

Media: Kathleen Reid; media@abcellera.com, +1(236)521-6774

Business Development: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005

Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When is AbCellera (ABCL) presenting at the Stifel Healthcare Conference in 2024?

AbCellera (ABCL) is presenting at the Stifel Healthcare Conference on Monday, November 18, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time).

What time is AbCellera's (ABCL) presentation at the Jefferies London Healthcare Conference in 2024?

AbCellera (ABCL) is presenting at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 10:00 a.m. Pacific Time (5:00 p.m. Greenwich Mean Time).

How can investors access AbCellera's (ABCL) presentations at the November 2024 conferences?

Investors can access live audio webcasts of AbCellera's (ABCL) presentations through links that will be posted on the company's Investor Relations website.

Will replays of AbCellera's (ABCL) November 2024 conference presentations be available?

Yes, replays of AbCellera's (ABCL) conference presentations will be available through the same links on the company's Investor Relations website following the live presentations.